Nut Hypersensitivity - 32 Studies Found
| Completed |
: A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy :
|
| Active, not recruiting |
: Peanut Oral Immunotherapy in Children : Peanut Hypersensitivity : 2013-05-23 :
|
| Completed |
: Epicutaneous Immunotherapy in Peanut Allergy in Children : Peanut Allergy : 2010-09-07 :
|
| Completed |
: Pilot Study to Evaluate the Effect of Ketotifen on the Adverse Events Associated With Peanut Desensitization : Peanut Allergies in Children : 2012-06-19 : Drug: Ketotifen titrated dose: 1 mg once a day, then 1 mg twice a day then 2 mg twice a day |
| Completed |
: PALISADE Follow-on Study (ARC004) : Peanut Allergy : 2016-12-08 : Biological: AR101 AR101 powder provided in capsules & sachets |
| Active, not recruiting |
: Oral Peanut Immunotherapy : Peanut Allergy : 2010-08-12 : Drug: Peanut flour OIT Patients will receive daily escalating dosages as determined in the modified rush |
| Enrolling by invitation |
: Identification of Anaphylactogenic Antibodies in Peanut Allergy : Peanut Allergy : 2016-06-29 : Other: Observational study Blood sampling |
| Active, not recruiting |
: Safety Study of Viaskin Peanut to Treat Peanut Allergy : Peanut Allergy : 2016-09-26 :
|
| Active, not recruiting |
: Treatment of Severe Peanut Allergy With Xolair (Omalizumab) and Oral Immunotherapy : Peanut Allergy : 2013-11-28 : Drug: Omalizumab Omalizumab is the treatment during oral immunotherapy with peanuts as protection |
| Active, not recruiting |
: Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy : Peanut Allergy : 2015-11-19 :
|